Immunovia AB (publ)
F:1YR
Immunovia AB (publ)
F:1YR
Price:
0.0001
EUR
Market Cap:
€7.6k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Immunovia AB (publ)
F:1YR
|
SE |
|
Y
|
Yuasa Battery (Thailand) PCL
SET:YUASA
|
TH |
|
Accelerated Technologies Holding Corp
OTC:ATHC
|
US |
Balance Sheet
Balance Sheet Decomposition
Immunovia AB (publ)
Immunovia AB (publ)
Balance Sheet Decomposition is not available for
Immunovia AB (publ)
Immunovia AB (publ)
Balance Sheet
Immunovia AB (publ)
Immunovia AB (publ)
Currency: SEK
| Dec-2013 | Dec-2014 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
4
|
32
|
259
|
192
|
386
|
263
|
468
|
287
|
106
|
77
|
25
|
|
| Cash |
0
|
0
|
0
|
0
|
386
|
263
|
468
|
287
|
106
|
77
|
25
|
|
| Cash Equivalents |
4
|
32
|
259
|
192
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
1
|
1
|
10
|
9
|
3
|
4
|
4
|
4
|
1
|
2
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Other Receivables |
0
|
1
|
0
|
0
|
8
|
3
|
4
|
4
|
3
|
1
|
2
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
2
|
4
|
2
|
2
|
3
|
4
|
3
|
2
|
|
| Total Current Assets |
4
|
77
|
261
|
204
|
399
|
269
|
475
|
297
|
116
|
81
|
29
|
|
| PP&E Net |
0
|
1
|
3
|
7
|
14
|
55
|
49
|
47
|
48
|
15
|
2
|
|
| PP&E Gross |
0
|
1
|
3
|
7
|
14
|
55
|
49
|
47
|
48
|
15
|
2
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
2
|
4
|
7
|
22
|
33
|
44
|
13
|
7
|
|
| Intangible Assets |
4
|
14
|
19
|
37
|
62
|
92
|
135
|
147
|
134
|
3
|
2
|
|
| Long-Term Investments |
0
|
0
|
0
|
3
|
3
|
3
|
3
|
3
|
4
|
1
|
1
|
|
| Total Assets |
8
N/A
|
92
+1 120%
|
283
+210%
|
251
-12%
|
477
+90%
|
419
-12%
|
661
+58%
|
494
-25%
|
301
-39%
|
99
-67%
|
33
-67%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
1
|
1
|
2
|
7
|
3
|
5
|
4
|
3
|
2
|
8
|
1
|
|
| Accrued Liabilities |
2
|
2
|
3
|
5
|
11
|
16
|
22
|
20
|
15
|
15
|
8
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
5
|
5
|
6
|
5
|
2
|
1
|
|
| Other Current Liabilities |
0
|
5
|
2
|
1
|
1
|
2
|
2
|
3
|
2
|
4
|
6
|
|
| Total Current Liabilities |
3
|
8
|
7
|
14
|
15
|
29
|
34
|
33
|
24
|
30
|
16
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
33
|
28
|
27
|
33
|
2
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
|
| Total Liabilities |
3
N/A
|
8
+208%
|
7
-12%
|
14
+106%
|
15
+10%
|
62
+300%
|
62
+0%
|
60
-3%
|
57
-5%
|
32
-44%
|
21
-32%
|
|
| Equity | ||||||||||||
| Common Stock |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
5
|
|
| Retained Earnings |
0
|
18
|
33
|
78
|
165
|
280
|
417
|
583
|
774
|
1 072
|
1 180
|
|
| Additional Paid In Capital |
5
|
0
|
0
|
0
|
0
|
0
|
1 015
|
1 016
|
1 016
|
1 136
|
1 186
|
|
| Other Equity |
0
|
101
|
309
|
314
|
626
|
637
|
1 015
|
0
|
1 016
|
0
|
0
|
|
| Total Equity |
5
N/A
|
84
+1 610%
|
277
+230%
|
237
-14%
|
462
+95%
|
358
-23%
|
599
+68%
|
434
-28%
|
244
-44%
|
67
-73%
|
12
-83%
|
|
| Total Liabilities & Equity |
8
N/A
|
92
+1 120%
|
283
+210%
|
251
-12%
|
477
+90%
|
419
-12%
|
661
+58%
|
494
-25%
|
301
-39%
|
99
-67%
|
33
-67%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
6
|
14
|
17
|
19
|
21
|
21
|
24
|
49
|
63
|
117
|
218
|
|
Switch to:
Switch to:
See Also
Discover More
